USA
Panacea closes second healthcare fund on $276m
Panacea Venture, a healthcare-focused investment firm established by James Huang, formerly a partner at KPCB China, has closed its second fund with approximately USD 276m in commitments.
TPG's Coulter calls for patience, perspective amid 'great reset' - AVCJ Forum
James Coulter, executive chairman and founding partner of TPG, told the AVCJ Private Equity & Venture Forum that the current “great reset” represents one of the most interesting periods in his career, although he advised investors to look beyond immediate...
Q&A: Northwestern University’s Tianhao Wu
Tianhao Wu, a managing director in the investment team at Northwestern University’s endowment, on adding new GP relationships, addressing China risk, and pursuing geographic diversification in Asia
Sport investment: Into the value chain
Investors are increasingly drawn to the structural nuances, sticky customer bases, and long tail of ancillary opportunities that exist around professional sports. Asia’s role is small but growing
Taking PE in-house: Less limited partners
Institutional investors continue to pursue more active roles in private equity, even as a souring macro backdrop makes the game harder to play. Talent is always the key variable
US logistics AI start-up gets $100m for Asia entry
US-based Altana Technologies, an artificial intelligence (AI) and analytics provider for the logistics industry, has raised USD 100m in Series B funding with plans to open a Singapore office in early 2023.
Deal focus: GPs pile into US-India tech corridor
US and India-based Accion Labs continues to collect private equity backers as it further globalises its IT services offering. Incoming investors don’t want to shake up the winning formula
Brookfield commits $500m to carbon recycling specialist LanzaTech
Brookfield Renewable, a business controlled by Brookfield Asset Management, has agreed to invest USD 500m in LanzaTech, a US carbon recycling specialist with a significant Asia presence.
China's Neushen Therapeutics gets $20m pre-Series A
China’s Neushen Therapeutics, a biotech developer focused on central nervous system (CNS) disorders, has raised USD 20m in pre-Series A funding led by local VC firm Lapam Capital.
India's True North buys stake in TA-backed Accion Labs
Indian middle market private equity firm True North has acquired a significant minority position in US and India-based IT provider Accion Labs from TA Associates for USD 93m.
China semiconductor: Casualties of war
Private equity investment in China’s semiconductor industry continues unabated despite intensifying US regulatory action. While start-ups are not explicitly targeted, many are feeling the heat
Australia's Telstra Ventures raises $336m for latest global fund
Australia’s Telstra Ventures has closed its third global fund on AUD 500m (USD 336m), beating a target of AUD 400m. Fund II closed on AUD 675m in 2018 and added a USD 50m sidecar the following year.
Bessemer closes latest global VC fund on $3.85b
US-based Bessemer Venture Partners, which is currently expanding a longstanding presence in India, has closed its latest global VC fund with USD 3.85m in commitments.
Q&A: Unitus Ventures’ Surya Mantha
Indian returns-focused impact investor Unitus Ventures is sharpening its thesis around jobs as it celebrates its 10-year anniversary. Surya Mantha, a managing partner at the firm, traces the evolution
Fund focus: Cherubic continues to scale
Early-stage investor Cherubic Ventures initially struggled to get traction with its idiosyncratic Greater China-US strategy, but the firm sees its USD 110m haul for Fund V as validation of the thesis
Prosperity7 backs China-founded unstructured data specialist Zilliz
Prosperity7 Ventures, a venture capital fund established by Saudi Arabia state oil giant Saudi Aramco, has led a USD 60m Series B extension for China-founded open-source software developer Zilliz.
US private debt player Waterfall launches in Hong Kong
Waterfall Asset Management, a US alternatives manager primarily active in the private debt space, has established an Asia presence with the opening of an office in Hong Kong.
India’s CleverTap raises $105m Series D
India and US-based customer engagement platform CleverTap has raised a USD 105m Series D round led by Caisse de depot et placement du Quebec (CDPQ).
Portfolio: CBC Group and Ensem Therapeutics
CBC Group plans to allocate USD 300m from its latest flagship fund to a biotech incubation platform. Artificial intelligence-enabled drug discovery player Ensem Therapeutics is an example of what it wants to achieve.
Seed platforms: Fishing minnows from ocean liners
Accelerators and seed investors are increasingly pursuing global mandates and building out large, international teams. The challenges are starting to cast shadows over the benefits, but it’s early days
Deal focus: China start-up mines 3D printing’s micro potential
Supported by a string of Chinese investors, Boston Micro Fabrication has carved a niche serving global manufacturers that want 3D printing solutions for very small components
Affirma supports Korea's NPX in Terapin Studios deal
Affirma Capital has confirmed a USD 38m investment in Terapin Studios, a US-based media platform controlled by Korea’s NPX Capital focused on bringing Korean digital comics to global markets.
Shenzhen Capital leads Series C for miniature 3D printing player
Shenzhen Capital Group has led a USD 43m Series C round for China and US-based Boston Micro Fabrication (BMF), which specialises in microscale 3D printing systems.
India's ChrysCapital adds US-based operating partner
India's ChrysCapital Partners has appointed Sanjay Jalona, formerly CEO of the IT division of Indian engineering conglomerate Larsen & Toubro, as an operating partner based in the US.